Skip to main content

Table 2 List of previous reports of individual miRNAs in biological processes or liver diseases of the liver and bile duct based on published literature (http://www.ncbi.nlm.nih.gov/pubmed, as of 5/3/2012)

From: Integrative genomics identifies candidate microRNAs for pathogenesis of experimental biliary atresia

Name

Relationship: liver

Relationship: bile duct

miR-126-3p

No report

No report

miR-30b

Inhibited TGF beta1-induced EMT, [24] downregulated after hepatectomy in rats [29]

Upregulated in LPS-induced Activated NFκB in cholangiocytes [25]

miR-30c

Required for hepatobiliary development [10]

Required for hepatobiliary development, [10] upregulated after C.parvum infection [26]

miR-151-3p

No report

No report

miR-320

Downregulated in Huh7 cells after HCV infection [21]

Downregulated in intrahepatic cholangiocarcinoma, involved in drug-triggered apoptosis [28]

miR-676

No report

No report

miR-204

No report

Downregulated in intrahepatic cholangiocarcinoma [28]

miR-193b

Downregulated in HCC, [13] upregulated in a HCC cell line after transfection of HCV genome [20]

No report

miR-365

No report

No report

miR-133a

No report

No report

miR-200b

Downregulated in HCC, [18, 19] upregulated in NAFLD and NASH [22, 23]

Upregulated in cholangiocarcinoma cell lines [27]

miR-133b

No report

No report

miR-200a

Downregulated in HCC [15] and inhibited the proliferation and migration of HCC cells, [17] upregulated in NAFLD [23]

No report

miR-195

Downregulated in HCC, [15] suppressed growth of HCC, [14] sensitized HCC to 5-fluorouracil, [16] inhibited proliferation of HSC [30]

No report

  1. TGF: transforming growth factor, LPS: lipopolysaccharide, HCC: hepatocellular carcinoma, HCV: Hepatitis C virus, EMT: epithelial-to-mesenchymal transition, NAFLD: nonalcoholic fatty liver disease, NASH: nonalcoholic steatohepatitis, HSC: hepatic stellate cells.